Peacock Karen 4
4 · IDEXX LABORATORIES INC /DE · Filed Dec 3, 2025
Insider Transaction Report
Form 4
Peacock Karen
Director
Transactions
- Award
Restricted Stock Unit
2025-12-01+101→ 101 total→ Common Stock (101 underlying) - Award
Non-Qualified Stock Option (right-to-buy)
2025-12-01+231→ 231 totalExercise: $727.97Exp: 2035-11-30→ Common Stock (231 underlying)
Footnotes (3)
- [F1]This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from the date of her election to the IDEXX Laboratories, Inc. Board of Directors on October 6, 2025 until the 2026 annual meeting of stockholders.
- [F2]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock and vest in one installment on May 7, 2026 or on the date of the 2026 annual meeting of stockholders, whichever event is earlier.
- [F3]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests in one installment on May 7, 2026 or on the date of the 2026 annual meeting of stockholders, whichever event is earlier.